Pramlintide
About
About Pramlintide
Pramlintide is a synthetic analog of amylin FDA-approved as an adjunct to mealtime insulin in type 1 and type 2 diabetes (brand: Symlin, NDA 021332). Amylin is co-secreted with insulin by pancreatic beta cells and is deficient in insulin-dependent diabetes. Pramlintide slows gastric emptying, suppresses postprandial glucagon, and reduces appetite. It is used off-label in obesity and GLP-1 combination protocols by metabolic physicians.
Science
Mechanism of Action
Amylin receptor agonist (AMY1–3, RAMP1–3 heterodimers). Activates area postrema and nucleus tractus solitarius circuits to suppress glucagon secretion after meals, delay gastric emptying, and signal satiety. Unlike GLP-1 agonists, pramlintide does not stimulate insulin release. Proline substitutions at positions 25, 28, 29 prevent amyloid fibril formation seen with native amylin.
Dosing
Typical Protocol
Type 1 DM: 15 mcg SC immediately before major meals, titrate to 30–60 mcg. Type 2 DM: 60 mcg SC before major meals, titrate to 120 mcg if tolerated. Must reduce mealtime insulin dose by 50% at initiation to avoid hypoglycemia. Administer in a separate syringe from insulin (incompatible in mixture). Requires physician supervision and glucose monitoring.
⚠ Protocol information is for educational purposes only. Dosing must be determined by a licensed physician based on individual health status and goals.
Regulatory
Legal Status in 2026
This compound has completed clinical trials and received formal FDA approval for one or more indications. It can be legally prescribed by licensed physicians, filled at any licensed pharmacy, and may be covered by insurance. Off-label use by physicians is also legal. This is the highest level of regulatory clearance available in the US.
Evidence
Evidence Tier
Supported by the clinical trial data required for FDA approval, representing the highest evidence bar. Safety and efficacy have been established in multiple phases of human clinical trials.
No verified providers offering Pramlintide yet
We audit new providers every week. Leave your email and we’ll let you know as soon as a Vial-verified provider starts offering Pramlintide.
Free. We’ll only email when there’s a real match.
This page evaluates compliance signals, not clinical outcomes. Consult a licensed physician before starting any therapy, medication, or treatment. Vial does not provide medical advice.